Cargando…
The impact of cytochrome P450 3A genetic polymorphisms on tacrolimus pharmacokinetics in ulcerative colitis patients
Tacrolimus (Tac) is an effective remission inducer of refractory ulcerative colitis (UC). Gene polymorphisms result in interindividual variability in Tac pharmacokinetics. In this study, we aimed to examine the relationships between gene polymorphisms and the metabolism, pharmacokinetics, and therap...
Autores principales: | Furuse, Maizumi, Hosomi, Shuhei, Nishida, Yu, Itani, Shigehiro, Nadatani, Yuji, Fukunaga, Shusei, Otani, Koji, Tanaka, Fumio, Nagami, Yasuaki, Taira, Koichi, Kamata, Noriko, Watanabe, Toshio, Watanabe, Kenji, Fujiwara, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062093/ https://www.ncbi.nlm.nih.gov/pubmed/33886687 http://dx.doi.org/10.1371/journal.pone.0250597 |
Ejemplares similares
-
Impact of the Lockdown Due to the COVID-19 Pandemic on Patients With Inflammatory Bowel Disease
por: Nishida, Yu, et al.
Publicado: (2021) -
Pretreatment neutrophil-to-lymphocyte ratio predicts clinical relapse of ulcerative colitis after tacrolimus induction
por: Nishida, Yu, et al.
Publicado: (2019) -
Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis
por: Nishida, Yu, et al.
Publicado: (2019) -
Effect of the Coronavirus Disease 2019 Lockdown on Lifestyle Factors in Japanese Patients with Inflammatory Bowel Disease
por: Nishida, Yu, et al.
Publicado: (2022) -
Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing
por: Kurimoto, Noriyuki, et al.
Publicado: (2023)